NCT03521622 (EFICO) is a NA clinical trial of brief counseling in Risk Behavior, sponsored by Hospital Universitario San Ignacio.

Who is sponsoring NCT03521622?

NCT03521622 is sponsored by Hospital Universitario San Ignacio.

What drugs are being tested in NCT03521622?

Interventions in NCT03521622: brief counseling.

What condition does NCT03521622 study?

NCT03521622 studies Risk Behavior.

Is NCT03521622 still recruiting?

NCT03521622 is currently completed. Last updated 13 March 2024.

Last reviewed 2024-03-13 · How we verify

NCT03521622: EFICO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Counseling Interventions to Modify Risk Behaviors in Patients at the Hospital San Ignacio.

Completed NA Last updated 13 March 2024

What this trial tests

NA trial testing brief counseling in Risk Behavior in 440 participants. Completed in 30 May 2020.

Timeline

15 April 2018

Primary endpoint
30 May 2019

30 May 2020

Quick facts

Lead sponsor	Hospital Universitario San Ignacio
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	screening
Enrollment	440
Start date	15 April 2018
Primary completion	30 May 2019
Estimated completion	30 May 2020
Sites	1 location across Colombia

Drugs / interventions tested

brief counseling

Conditions studied

Risk Behavior — all drugs for Risk Behavior →

Sponsor

Hospital Universitario San Ignacio

Who can join

Adults 19 to 64, any sex, with Risk Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized clinical trial that aims to determine the effectiveness of a counseling intervention to modify the stage of behavioral change in risk behaviors (smoking and risky alcohol consumption) in patients candidates for scheduled surgery or diagnostic procedures at the Hospital Universitario de San Ignacio. Bogotá-Colombia

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries.
Greene MC, Kane J, Alto M, Giusto A, et al · · 2023 · cited 7× · PMID 37158538 · DOI 10.1002/14651858.cd013350.pub2
Brief counseling for smoking cessation and alcohol use reduction concomitant with hospital procedures: a randomized clinical trial.
Alba LH, Penãloza M, Olejua P, Cespedes E, et al · · 2022 · cited 3× · PMID 36420908 · DOI 10.47626/1516-4446-2021-2413
Effectiveness of brief counselling in a hospital setting for smoking cessation and risky alcohol drinking reduction: randomised clinical trial protocol.
Ingrid A, Olaya L, Cuevas V, Castillo JS, et al · · 2022 · PMID 35717385 · DOI 10.1016/j.rcpeng.2020.06.003
Effectiveness of Brief Counseling in a Hospital Setting for Smoking Cessation and Risky Alcohol Drinking Reduction: Randomized Clinical Trial Protocol.
Almonacid I, Olaya L, Cuevas V, Castillo JS, et al · · 2020 · PMID 33735015 · DOI 10.1016/j.rcp.2020.06.005

Verify or expand the search:

Other recruiting trials for Risk Behavior

Currently open trials in the same condition.

NCT05522647 — Detection of Risk Behaviors: Pilot Observational Study With Bedridden and Agitated Patients. · recruiting
NCT07255300 — Follow up Study of Varapodio Trial: Effect of Longevity and Fasting Mimicking Diet on Risk Factors Age Correlated and Bi · NA · recruiting
NCT06311838 — Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessne · NA · recruiting
NCT06105853 — Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder · NA · recruiting
NCT03337009 — The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy · NA · active not recruiting

Other Hospital Universitario San Ignacio trials

Trials by the same sponsor.

NCT07308925 — Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 D · NA · not yet recruiting
NCT06728423 — Comparison of SmartGuard vs Temp Target in Patients With Type 1 Diabetes Users of Advanced Hybrid Closed Loop System (AH · NA · not yet recruiting
NCT06857110 — "Supracondylar Radial Nerve Block Guided by Ultrasound Versus Hematoma Block for Analgesic Management in Closed Reductio · NA · recruiting
NCT06856824 — Functional Results of Infiltration for Biceps Tendonitis Guided by Ultrasound vs Anatomical Repairs: Variation in Techni · NA · recruiting
NCT06766747 — Efficacy of Intermittent Fasting Versus Continuous Caloric Restriction in the Treatment of Significant Weight Regain Aft · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03521622 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario San Ignacio
Last refreshed: 13 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03521622.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing